What does Dr. ESMANS do?

Dr. ESMANS is a specialist medical practice in Antwerpen. Private Limited, started on 7 January 2008, 1 establishment.

What is the address of Dr. ESMANS?

The registered office of Dr. ESMANS is located at Dageraadplaats 23, 2018 Antwerpen.

Is Dr. ESMANS still active?

Yes. According to the CBE (7 October 2026) Dr. ESMANS is active, legal situation “Normale toestand”, started on 7 January 2008.

Is Dr. ESMANS registered on Peppol?

No, Dr. ESMANS is currently not registered on the Peppol network.

What is the enterprise number of Dr. ESMANS?

The enterprise number of Dr. ESMANS is BE0894671976.

When was Dr. ESMANS founded?

Dr. ESMANS was founded on 7 January 2008.

Who are the directors of Dr. ESMANS?

According to the 2025 annual accounts, the directors of Dr. ESMANS are: ANJA ESMANS.

Is Dr. ESMANS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 January 2008; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. ESMANS make in 2025?

Dr. ESMANS posted a profit after taxes of € 47,905 in financial year 2025.

What is the revenue of Dr. ESMANS?

As a small company, Dr. ESMANS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 73,317.

Dr. ESMANS (Private Limited) - Antwerpen - BE0894671976

Dossier Dr. ESMANS, printed on 7 October 2026 from databakkes.be/en/0894671976/dr-esmans. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 43 % of short-term debt in 2025; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. ESMANS from Antwerpen, company number BE0894671976, closed financial year 2025 with a result of € 47,905 after tax. For that financial year Dr. ESMANS recorded a gross margin of € 73,317 and equity of € 251,239. Compared with financial year 2024, the result moved from € 20,210 to € 47,905. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Healthy

€ 251,239

▼ 38% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 47,905

▲ 137% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 70,339

▲ 122% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 200,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 14,176

▼ 8% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 21,917

▼ 39% vs 2024

€ 17,177 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 3,669

▲ € 3,004 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 23,646

▲ € 21,909 vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -46,049 Gross margin 2022: € -46,049 First fiscal year in the series	€ 16,282 Gross margin 2023: € 16,282 ▲ € 62,331 vs 2022 (€ -46,049) Favourable step	€ 50,337 Gross margin 2024: € 50,337 ▲ 209% vs 2023 (€ 16,282) Favourable step	€ 73,317 Gross margin 2025: € 73,317 ▲ 46% vs 2024 (€ 50,337) Favourable step	▲ 46%
Profit after taxes	€ -70,394 Profit after taxes 2022: € -70,394 First fiscal year in the series	€ -9,842 Profit after taxes 2023: € -9,842 ▲ € 60,552 vs 2022 (€ -70,394) Favourable step	€ 20,210 Profit after taxes 2024: € 20,210 ▲ € 30,052 vs 2023 (€ -9,842) Favourable step	€ 47,905 Profit after taxes 2025: € 47,905 ▲ 137% vs 2024 (€ 20,210) Favourable step	▲ 137%
Equity	€ 398,467 Equity 2022: € 398,467 First fiscal year in the series	€ 388,625 Equity 2023: € 388,625 ▼ 2% vs 2022 (€ 398,467) Unfavourable step	€ 403,335 Equity 2024: € 403,335 ▲ 4% vs 2023 (€ 388,625) Favourable step	€ 251,239 Equity 2025: € 251,239 ▼ 38% vs 2024 (€ 403,335) Unfavourable step	▼ 38%
Total debts	€ 80,304 Total debts 2022: € 80,304 First fiscal year in the series	€ 64,598 Total debts 2023: € 64,598 ▼ 20% vs 2022 (€ 80,304) Favourable step	€ 43,856 Total debts 2024: € 43,856 ▼ 32% vs 2023 (€ 64,598) Favourable step	€ 234,777 Total debts 2025: € 234,777 ▲ € 190,922 vs 2024 (€ 43,856) Unfavourable step	▲ € 190,922
Cash	€ 18,338 Cash 2022: € 18,338 First fiscal year in the series	€ 31,052 Cash 2023: € 31,052 ▲ 69% vs 2022 (€ 18,338) Favourable step	€ 31,683 Cash 2024: € 31,683 ▲ 2% vs 2023 (€ 31,052) Favourable step	€ 70,339 Cash 2025: € 70,339 ▲ 122% vs 2024 (€ 31,683) Favourable step	▲ 122%
Retained profit	€ 379,867 Retained profit 2022: € 379,867 First fiscal year in the series	€ 370,025 Retained profit 2023: € 370,025 ▼ 3% vs 2022 (€ 379,867) Unfavourable step	€ 384,735 Retained profit 2024: € 384,735 ▲ 4% vs 2023 (€ 370,025) Favourable step	€ 232,639 Retained profit 2025: € 232,639 ▼ 40% vs 2024 (€ 384,735) Unfavourable step	▼ 40%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 5,500 Dividend 2024: € 5,500 Unchanged (€ 0) Unchanged	€ 200,000 Dividend 2025: € 200,000 ▲ € 194,500 vs 2024 (€ 5,500) Unchanged	▲ € 194,500
Bank debt	€ 64,205 Bank debt 2022: € 64,205 First fiscal year in the series	€ 49,211 Bank debt 2023: € 49,211 ▼ 23% vs 2022 (€ 64,205) Favourable step	€ 35,705 Bank debt 2024: € 35,705 ▼ 27% vs 2023 (€ 49,211) Favourable step	€ 21,917 Bank debt 2025: € 21,917 ▼ 39% vs 2024 (€ 35,705) Favourable step	▼ 39%
Balance sheet total	€ 478,771 Balance sheet total 2022: € 478,771 First fiscal year in the series	€ 453,223 Balance sheet total 2023: € 453,223 ▼ 5% vs 2022 (€ 478,771) Unchanged	€ 447,190 Balance sheet total 2024: € 447,190 ▼ 1% vs 2023 (€ 453,223) Unchanged	€ 486,017 Balance sheet total 2025: € 486,017 ▲ 9% vs 2024 (€ 447,190) Unchanged	▲ 9%

Key figures of Dr. ESMANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. ESMANS?

What happened at Dr. ESMANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2026 New annual accounts for financial year 2025: profit of € 47,905 (▲ 137% vs 2024). filed late Source: NBB ↗
Jan 7, 2008 Start of the company according to the CBE. KBO
Dec 27, 2007 New establishment in Antwerpen. KBO

In short

From € 70,394 loss in 2022 to € 47,905 profit in 2025.

Paid € 11,357 in corporate taxes since 2022.

Best year ever: 2025, with € 47,905 profit.

Paid out € 205,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. ESMANS? We notify you, reason included.

Follow Dr. ESMANS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

ANJA ESMANS

Dr. ESMANS

Behind Dr. ESMANS is ANJA ESMANS.

See the full network in the app

Directors

According to the 2025 annual accounts

ANJA ESMANS

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Dageraadplaats 23

2018 Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0894.671.976
VAT number: BE 0894.671.976
Registered office: Dageraadplaats 23, 2018 Antwerpen
Names & denominations: Dr. ESMANS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 January 2008
Peppol: Not registered
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗